chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure; I know a person that got the shot then got the shingles!; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient got the shingles shot then got the shingles. This case was considered as suspected vaccination failure since the details regarding time to onset, completion of primary vaccination  schedule and laboratory confirmation of shingles was not provided.
I got the second shot on oct 16 and towards the end of October I started noticing blurred vision occasionally. I still notice it occasionally happening.
This was BOOSTER.  Later that evening had flu symptoms. Very sore arm with heat and pain at injection site;  Fever with chills; Fatigue; Body aches; Mental sadness; Some nausea.
pt recv vax 11AUG95 inj site rt upper arm;called ofc on 18AUG reported inc pain, redness in rt arm @ site;MD examined pt reported 2x2 indurated area size of silver dollar;22AUG pt had emergency surgery unrelated to rxn
Starting 06/18/2022, I developed a headache, sore throat and chills/aches and pains. The sore throat worsened and it was very bad, no cough but I felt very tired, was achy and had chills. I took an at-home test on 06/18/2022 and 06/19/2022 but both were negative. On 06/20/2022, I took another at-home COVID-19 test which was positive. So, I called my doctor who prescribed me PAXLOVID. I started the PAXLOVID on 06/21/2022. By 06/23/2022, I was feeling much better. The sore throat was gone. I was still a little fatigued but it was much better. No relapses.
Metallic taste in mouth. Ringing in ears. Dizzy. Pale. Nearly passed out & had to lay down. After about 30 minutes symptoms started to resolve. Ringing & metallic taste continued to come & go throughout the rest of the day. Neck pain the next 2 days.
sniffles every time; Initial information was received on 15-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional via social media.  This case involves a patient of unknown age and gender who experienced sniffles every time (rhinorrhoea), while he/she received vaccine INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor and the patient's past medical treatment(s), vaccination(s), family history and concomitant medication were not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious sniffles every time (rhinorrhea) (Unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events. Medication details and reason for taking the medicine: Product Name: Product name was not provided. Since this was a public post it was assumed the consumer was referring to the Sanofi flu vaccine.  Details of laboratory data were not reported.  Patient was treated with mild antibiotic.  At the time of reporting, outcome of the event was unknown.  Result of assessment was not reported.  There will be no information available on batch number for this case.
After patient left office arm were the vaccines were given started to turn red with irritation. Next day patient experienced headaches, chills, ear aches, joint pain, and loss of appetite. Rash grew to cover most of the upper arm with swelling.
Patient came in the pharmacy on 09/22/2023 at 10:00 to report his experiences: 09/18/2023  He was just laying in bed not feeling well. 09/19/2023  He got paralysis, fever, pain, muscle aches and nasal symptoms. (took Tylenol) 09/22/2023  He is fine now.  He said the reactions are from the RSV Patient received Flublok in 08/30/2021 and 09/28/2022 without any complication.
1st dose before pandemic, 2nd dose not given; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown time before the pandemic).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose before pandemic, 2nd dose not given). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 30-MAR-2023 The reporter reported that a patient had not yet received the 2nd dose of Shingrix. Adverse event report contained all reported information.  The patient information, LOT number, expiration date and date of administration unavailable for this patient per healthcare professional.  The reporter gave consent for safety team follow up.  Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The case had been linked to US2023048008, reported by the same reporter, for a different patient.; Sender's Comments:  US-GSK-US2023048008:same reporter
11pm :Heart racing that woke me from sleep. Metal taste in mouth. Drank water and it tasted like metal.  7 am Any liquids I drank, coffee with cream, and water tasted like metal and seemed thicker. Excessive thirst. Feeling faint and disoriented. Off balance. Did not feel comfortable driving.
Breakthrough case admission after 2 vaccines Pfizer 5/20/21 Lot# Ew0186;  Pfizer 6/10/21 lot# Ew0178
Information has been received from a 25 year old female medical assistant concerning herself who in December 2008, was vaccinated with a dose of GARDASIL. In May 2009, the patient experienced an abnormal PAP. It was not known if the patient received all three doses of GARDASIL. At the time of reporting, the outcome was unknown. The patient sought unspecified medical attention. No further information is available.
Information has been received from a 63 year old male consumer with no pertinent medical history reported who on 23-AUG-2007 was vaccinated with a dose of ZOSTAVAX vaccine (Merck) (dose, route and lot number not provided). There was no concomitant medication. On 27-APR-2009 the patient's wife saw a spider bite looking bump on his arm and it started to spread on his arm. The patient reported that he was supposed to have an unspecified surgery on 29-APR-2009 but it was hold off because during the prescreening for surgery, they saw the bump and he was told to go back to his family physician to have the bump checked. the patient reported that his physician noted that this was shingles. At the time of reporting the patient had not recovered from the event. Additional information has been requested.
Sx began with itchy spot on right back/ flank area.  Was also feeling painful at times.  He came in to urgent care 09/21/11 and was diagnosed with shingles.
Vomiting; This is a spontaneous report from a contactable consumer, the patient. An 81-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 18Feb2021 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 28Jan2021 at 14:30 as a single dose for COVID-19 immunisation. On 15Mar2021, the patient experienced vomiting. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vomiting was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient  is fully vaccinated and received a pfizer monovalent instead  of bivalent booster.   No adverse events/reaction. Patient advised to receive a bivalent booster after 2 months.
1/2 of arm red, swollen, warm from vaccine site to elbow, with blistered appearing center at injection site.
all of a sudden cannot walk without holding on to someone or using a cane; even then I feel very unstable; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (all of a sudden cannot walk without holding on to someone or using a cane) and FEELING ABNORMAL (even then I feel very unstable) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT INABILITY (all of a sudden cannot walk without holding on to someone or using a cane) and FEELING ABNORMAL (even then I feel very unstable). At the time of the report, GAIT INABILITY (all of a sudden cannot walk without holding on to someone or using a cane) and FEELING ABNORMAL (even then I feel very unstable) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Muscle aches, Headache, Malaise, Sore at injection site x5 days,  nausea and vomiting at day 2.  Injection site still has not completely healed, itched,  scabbed over and then bled repeatedly.  Scabbed over currently, but not healed and gone.
feeling anxious, heart palpitations, heart rate was 200. Started to level out but stayed elevated. Short of breath
Pt had fever and headache within 1 hr.  This went away about 9 pm.  The next day patient was ok.  On day 2  post vaccine (12/20/2020) patient woke up with lymph node swelling in his left armpit.  It was about palm size.  Pt took meloxicam on that day and next day.  Swelling has started to decrease.
Left thigh slight area of warm tender induration, hematoma slight 2 days after injection.
This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX (batch number Y24KE, expiry date 11th October 2020) for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced injection site pain and product supply issue. On an unknown date, the outcome of the injection site pain and product supply issue were unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHIGRIX in the unknown deltoid. The healthcare professional asked that, was there any information for the Gluteus alternate injection site or any studies done on the Gluteus site. The patient had a reaction to the 1st dose of SHINGRIX and did not want the 2nd dose on the deltoid region. The healthcare professional asked that, how to proceed when the patients were missing 2nd dose due to SHINGRIX availability. The healthcare professional unable to provide the patient information.
Patient with 3 COVID vaccines who admitted to hospital with positive COVID test.  Patient hypoxic during stay, also having CHF exacerbation and in fluid overload.  Provider note:  "COVID-19 Vaccinated x 2 with 1 booster with Moderna. Symptom onset the day of admission.  Actually suspect this is related more to heart failure than COVID Chest x-ray shows fluid, no definitive evidence of superimposed bacterial pneumonia -steroids not indicated as he has no increased oxygen requirements"
Sinus pressure, excessive discharge of clear mucus from nose, general symptoms of severe cold, lasting 10-14 days.  Treatment antihistamine, aspirin.  After 1st booster had same symptoms, although less severe, lasting about 7 days.
Information has been received from a physician, for VARIVAX (Merck), a Pregnancy Registry product, concerning a 17 year old female with none drug reactions a history of sickle cell trait, who on 09-JAN-2012 was vaccinated SQ with a dose of VARIVAX (Merck) (dose unknown, Lot # 670559, 0864AA) while she was pregnant, (exp. 06-JUN-2013). Concomitant therapy included pregnancy vitamins (unspecified). The estimated delivery due date was 13-AUG-2012 and last menstrual period was approximately 07-NOV-2011. Pregnancy test and ultrasound were performed. No adverse effect reported. The patient sought unspecified medical attention. Follow-up information has been received from an OB/GYN physician concerning the patient with 0 number of previous pregnancy who on 09-JAN-2012 (also reported as 09-JAN-2011) was vaccinated SQ with a dose of VARIVAX (Merck) (0.5 mL, Lot # 670559/0864AA). The patient was tested for varicella antibodies before vaccination with VZV containing vaccine on 27-DEC-2011 and the result was positive. The date of last menstrual period was unspecified and the estimated delivery date was 13-AUG-2012. Ultrasound test was performed on 12-MAR-2012 for level ii sono and the result was noseval accessory. No maternal adverse event reported. Follow up information received from a physician refers to a female patient that the patient delivered a full term healthy infant at 39 weeks on 08-AUG-2012. The physician did not report the infant's weight or sex, but reported that there were no abnormalities in the delivery record. She also reported that two gestational ultrasounds done during pregnancy showed no congenital anomalies in the fetus. There was no further information reported. Additional information is not expected.
Patient reported feeling faint after receiving vaccine. He also reported blurring vision, which was resolved after about a minute after lying down on the floor. He was brought back at 12:46 and was given water and was laid down on the stretcher. VS were first taken at 12:50: HR: 51, RR: 20, BP: 110/50, SPO2: 100.  1:04 VS were: HR: 61, RR: 20, BP: 106/64, SPO2: 98.  Final VS were at 1:17: HR: 59, BP: 116/67, SPO2: 98. The patient was released at 1:17 by himself.
1 1/2 hr p/vax pt devel a severe h/a 4hr later nausea & crying w/pain unrelieved by APAP
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 22-FEB-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (exact dose and route of administration were not reported, lot # reported as L045676, expiration date 09-MAY-2017). There was no adverse effect reported. Additional information has been requested.
about five min after getting shot pt passed out, hit his head, started having a seizure and incontance issues. he was unconscious for several minutes. after waking up he was dizzy, nausous, and light-headed. paramedics wetre called and checked him out. he refused to go with them and his parents came and picked him up.
Pt. became dizzy upon administering shots, (2:50pm), unrelieved by laying down with legs elevated. Gave juice and ice pack and pt continued to feel dizzy. Vitals WNL, but pt. not improving. Placed pt. on O2 and called EMS. Arrived around 3:09 and pt. became hypotensive: 148/107. EMS transferred to hospital.
cold; fever ramped up all day long; chills/shivering; horrible joint pain like its on fire; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), PYREXIA (fever ramped up all day long), CHILLS (chills/shivering) and ARTHRALGIA (horrible joint pain like its on fire) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048F21A and 016B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (he might have COVID-19 in January 2021 but there were no available COVID-19 test that time) in January 2021, Intermittent fever from January 2021 to February 2021 and Fatigue from January 2021 to February 2021. Concurrent medical conditions included Blood disorder (makes her susceptible to Deep vein thrombosis) and Allergic reaction to antibiotics (Tetracycline and Clindamycin).   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2021, the patient experienced NASOPHARYNGITIS (cold), PYREXIA (fever ramped up all day long), CHILLS (chills/shivering) and ARTHRALGIA (horrible joint pain like its on fire). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form and PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 UNK. On 13-Sep-2021, NASOPHARYNGITIS (cold), CHILLS (chills/shivering) and ARTHRALGIA (horrible joint pain like its on fire) had resolved. On 14-Sep-2021, PYREXIA (fever ramped up all day long) had resolved.            No concomitant medication information provided.   This case was linked to MOD-2021-320189 (Patient Link).
COUGH, SORE THROAT, BODY ACHE, HEAD ACHE,
Information has been received from a pharmacist referring to four unspecified patients of unknown age and gender. The patients' pertinent medical history and drug reactions/allergies were not reported. On 24-JUN-2015 the patients were vaccinated with expired doses of M-M-R II, lot # J006953 (dose and route were not reported). All four doses of M-M-R II had an expiration date of 07-JUN-2015. No adverse events were reported. Additional information has been requested.
Information has been received from a licensed visiting nurse concerning a 42 year old female patient who in 2001 was vaccinated with the first 0.5ml dose of VARIVAX (Merck) subcutaneously.  In 2002, the patient received the second 0.5ml dose of VARIVAX (Merck) (lot #635795/0778L) subcutaneously.  There were no drug reactions, allergies, other medical history and concomitant medication.  On 01-JUN-2009, the patient did the titer test, the result showed failing to seroconvert after receiving 2 doses of vaccine.  The patient had sought physician's medical attention.  Additional information has been requested.
Narrative: COVID infection following COVID vaccine series 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 09/03 pt cc: cough, chills, fever, headache, myalgias, rhinrrhea, dyspnea, sore throat exposure: unknown 09/07 COVID swab, result: detected 09/07 SARS-COV-2 Variant Sequencing result: pending 09/15 clinically resolved
no adverse effects; Improperly stored administered doses; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided.  On 24-MAY-2019, the patient was vaccinated with improperly stored  measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # R015745, expiration date 02-DEC-2019; dose and route unknown) for prophylaxis. The vaccine was exposed to temperature excursion from -14 to 10 degrees Celsius (C) for 15 hours. Data logger involved. There was no previous temperature excursion. No adverse effects were reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-1906USA000180:
-Swollen arm (3 inch diameter, 1/4" raised) at injection site. Pat claims slightly dizzy. -Recommended NSAIDS, ice site, antihistamines. -Recommended sec MD immediately. -So far no tx started per pt.
ALTE episode with limpness, cyanosis and apnea x 50 seconds.
Difficulty breathing for a day. Baseball size lump on arm & hand about 4" diameter redness surrounding injection site. It is now 5 days with reaction & still swollen & red.
101 fever, headache, heartburn, dizziness, pain at injection site, muscle aches, weakness, fatigue
Child developed right sided seizure lasting 15 minutes with no change in color 12 hours after vaccination. Temperature 105; brought to ER and admitted. Per review of hospital d/c summary, final diagnoses were right otitis media and cerebral hemispheric gray matter heterotopia.
Within twelve hours of getting three vaccines, I experienced soreness and tenderness at the injection sites. Then, fever (101.2); muscle, joint and body aches; extreme fatigue; weakness; joint pain; difficulty walking. Today - day 4 - left arm tenderness minimal, but unable to use right arm because of pain and tenderness of whole deltoid area; joint pain and fatigue and difficulty walking persists.
Case number PHEH2014US025154, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 87 years old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 22 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
On  2/17/2021 (2nd dose)about 4 p.m. started feeling nauseous and dizzy-injection arm became very sore. The next 2 days t he same as late afternoon on the day of injection.  2/20/2021 woke up feeling fine. 2/21, 2/22 back to feeling nauseous and dizzy with the injection arm hurting a lot. 2/22, 2,24, 2/25 were fairly good days. But 2/26 woke up at 3:30 a.m. feeling very, very nauseous and then vomiting violently and again at 6:30a.m. and 8:30a.m. (along with a bad case of diarrhea. Was  nauseous for the next 3 days and could not move my left arm above my elbow.
This spontaneous report was received from a female consumer of unknown age regarding herself. The patient's demographics were unknown. There was no information or pertinent medical history and drug reactions or allergies. On an unknown date, the patient was vaccinated with PNEUMOVAX23 (dose, units, product, lot#, expiry date, route not reported). The patient reported that after receiving PNEUMOVAX23 her entire arm swelled terribly. There was no product quality complaint involved. The outcome of the event was unknown. Additional information has been requested.
Site red, warm, swollen. Colleague c/o headache, nausea, diarrhea, dizziness, arm and chest pain with general weakness. ER doctor feels only local symptoms are related, and she may have a virus.